Pay in 4 interest-free payments of $6.70 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
A digitally delivered, individualized behavior change program for people who are at risk of developing type 2 diabetes
21 Liraglutide showed no effect on the hierarchical primary endpoint of time to death, time to rehospitalisation for HF and time-averaged change in N-terminal pro B-type natriuretic peptide (NT-proBNP) from baseline to 180 days (p=0.31), with even an increased risk of emergency department visit, HF hospitalisation or all-cause death events (HR 1.36
Wagner BK (2022) Small-molecule discovery in the pancreatic beta cell
in Florida, Mochi Medical CA, P.C
46 (2), e118e125
US$ 27.22
US$ 20.85
US$ 29.20
US$ 24.88
US$ 24.67
